In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
This content is intended for U.S. Healthcare Professionals. Would you like to proceed?
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
LAB-0083-5.0 Revised June 2019
Close clinical surveillance of all women taking estrogens is important. Adequate diagnostic measures including endometrial sampling,...
DEPO-Estradiol Injection is indicated in the treatment of:
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.
Estrogens should not be used in individuals with any of the following conditions:
See BOXED WARNINGS
Estrogen and estrogen/progestin...
See BOXED WARNINGS, WARNINGS and PRECAUTIONS.
Chlorobutanol anhydrous (chloral derivative) added as a preservative may be habit forming.
Serious ill effects have not been reported following acute ingestion of large doses of estrogen-containing oral contraceptives by young children. Overdosage of estrogen may cause nausea and vomiting, and withdrawal...
DEPO-Estradiol Injection contains estradiol cypionate for intramuscular use. Each mL contains:
5 mg/mL—5 mg estradiol cypionate, 5.4 mg chlorobutanol anhydrous (chloral derivative) added as preservative; in...
Endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Although circulating estrogens exist in a dynamic...
DEPO-Estradiol Injection is available in the following concentration containing per mL:
5 mg estradiol cypionate; also 5.4 mg chlorobutanol anhydrous (chloral deriv.) added as...
Brand of estradiol cypionate injection, USP
Read this PATIENT INFORMATION before you start taking...
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information.
Submit a medical question for Pfizer prescription products.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.